Design, synthesis, biological evaluation and computational studies of 4-Aminopiperidine-3, 4-dihyroquinazoline-2-uracil derivatives as promising antidiabetic agents
Ladan Baziar, Leila Emami, Zahra Rezaei, Aida Solhjoo, Amirhossein Sakhteman, Soghra Khabnadideh · 2024
Read Design, synthesis, biological evaluation and computational studies of 4-Aminopiperidine-3, 4-dihyroquinazoline-2-uracil derivatives as promising antidiabetic agents by Ladan Baziar, Leila Emami, Zahra Rezaei, Aida Solhjoo, Amirhossein Sakhteman, Soghra Khabnadideh (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11532418.txt.
Description
Ladan Baziar and co-authors report a 2024 study of new compounds aimed at type 2 diabetes. The target is an enzyme called DPP4, which breaks down hormones that help control blood sugar. Blocking the enzyme is a known drug route, and the team designed a fresh series of blockers.
The compounds were built in the lab and their forms were checked by standard scans. One compound, with a chlorine swap on a key ring, blocked the enzyme best in kit tests. Safety screens cleared the series, and rate studies showed the lead compound competes for the enzyme active site. Computer models backed the design, showing firm binding and a stable fit over time.
Catalog record
| CREATOR | Ladan Baziar, Leila Emami, Zahra Rezaei, Aida Solhjoo, Amirhossein Sakhteman, Soghra Khabnadideh |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |